- Home
- MMYT vs ROIV Comparison
MMYT vs ROIV Comparison
Compare MMYT & ROIV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MMYT
- ROIV
- Stock Information
- Founded
- MMYT 2000
- ROIV 2014
- Country
- MMYT India
- ROIV United Kingdom
- Employees
- MMYT N/A
- ROIV N/A
- Industry
- MMYT Transportation Services
- ROIV Biotechnology: Pharmaceutical Preparations
- Sector
- MMYT Consumer Discretionary
- ROIV Health Care
- Exchange
- MMYT Nasdaq
- ROIV Nasdaq
- Market Cap
- MMYT 9.0B
- ROIV 8.6B
- IPO Year
- MMYT 2010
- ROIV N/A
- Fundamental
- Price
- MMYT $92.62
- ROIV $16.05
- Analyst Decision
- MMYT Strong Buy
- ROIV Strong Buy
- Analyst Count
- MMYT 3
- ROIV 8
- Target Price
- MMYT $120.00
- ROIV $19.94
- AVG Volume (30 Days)
- MMYT 922.9K
- ROIV 9.1M
- Earning Date
- MMYT 10-21-2025
- ROIV 11-11-2025
- Dividend Yield
- MMYT N/A
- ROIV N/A
- EPS Growth
- MMYT N/A
- ROIV N/A
- EPS
- MMYT 0.86
- ROIV N/A
- Revenue
- MMYT $992,663,000.00
- ROIV $23,233,000.00
- Revenue This Year
- MMYT $23.37
- ROIV N/A
- Revenue Next Year
- MMYT $21.46
- ROIV $248.22
- P/E Ratio
- MMYT $109.37
- ROIV N/A
- Revenue Growth
- MMYT 18.13
- ROIV N/A
- 52 Week Low
- MMYT $81.84
- ROIV $8.73
- 52 Week High
- MMYT $123.00
- ROIV $16.79
- Technical
- Relative Strength Index (RSI)
- MMYT 42.34
- ROIV 77.85
- Support Level
- MMYT $92.08
- ROIV $15.25
- Resistance Level
- MMYT $96.54
- ROIV $16.79
- Average True Range (ATR)
- MMYT 2.71
- ROIV 0.44
- MACD
- MMYT -0.26
- ROIV 0.03
- Stochastic Oscillator
- MMYT 13.90
- ROIV 72.93
About MMYT MakeMyTrip Limited
MakeMyTrip Ltd is an online travel company, which provides online booking solutions for day-to-day travel needs. The company's operating segment includes Air ticketing; Hotels and packages; Bus ticketing and Others. It generates maximum revenue from the Hotels and packages segment. The Hotels and packages segments include internet-based platforms, call-centers, and branch offices, which provide holiday packages and hotel reservations. Its Air ticketing segment includes internet-based platforms, provides the facility to book domestic and international air tickets. Geographically, it derives a majority of revenue from India and also has a presence in the United States; South East Asia; Europe, and other countries.
About ROIV Roivant Sciences Ltd.
Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.